Literature DB >> 15920048

Frequency, severity, and morbidity of hypoglycemia occurring in the workplace in people with insulin-treated diabetes.

Alastair M Leckie1, Mairi K Graham, Joan B Grant, Peter J Ritchie, Brian M Frier.   

Abstract

OBJECTIVE: Hypoglycemia was examined in regularly employed people with insulin-treated diabetes to ascertain the frequency and consequences of this problem in the workplace. RESEARCH DESIGN AND METHODS: A prospective 12-month survey of 243 employed people (age range 20-69 years) with insulin-treated diabetes was performed to record the frequency, severity, and morbidity of hypoglycemia occurring at work. Details of hypoglycemic episodes included time of day, place, activity, causation, blood glucose, treatment, and morbidity. Serial HbA(1c) measurements were recorded.
RESULTS: A total of 1,955 mild (self-treated) episodes of hypoglycemia (8 per person per annum) and 238 severe (requiring external help) episodes (0.98 per person per annum) were recorded. Of the severe hypoglycemic episodes, 148 (62%) occurred at home, 35 (15%) occurred at work in 27 (11%) people (0.14 episodes per person per annum), and 54 (23%) occurred elsewhere; 52% of severe episodes occurred during sleep. Of the severe hypoglycemic episodes reported, adverse events were described in 54 (23%), with 29 losing consciousness (14%), 21 having a seizure (9%), 4 (2%) sustaining a head injury, 5 (2%) suffering another injury, 3 (1%) injuring someone else, and 2 (1%) damaging property. Severe hypoglycemia in the workplace was associated with six episodes of minor soft-tissue injuries.
CONCLUSIONS: In this cohort, severe hypoglycemia in the workplace was uncommon and seldom caused disruption or serious morbidity. On the basis of the frequency and severity of hypoglycemia observed in the present study, restriction of employment opportunities for most people with insulin-treated diabetes may be difficult to justify.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15920048     DOI: 10.2337/diacare.28.6.1333

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  12 in total

Review 1.  Reporting Severe Hypoglycemia in Type 1 Diabetes: Facts and Pitfalls.

Authors:  Ulrik Pedersen-Bjergaard; Birger Thorsteinsson
Journal:  Curr Diab Rep       Date:  2017-10-28       Impact factor: 4.810

2.  Metabolic environment in substantia nigra reticulata is critical for the expression and control of hypoglycemia-induced seizures.

Authors:  Libor Velísek; Jana Velísková; Ondrej Chudomel; Ka-Lai Poon; Kimberly Robeson; Barbara Marshall; Archana Sharma; Solomon L Moshé
Journal:  J Neurosci       Date:  2008-09-17       Impact factor: 6.167

3.  "Symptom-based insulin adjustment for glucose normalization" (SIGN) algorithm: a pilot study.

Authors:  Joyce Yu-Chia Lee; Keith Tsou; Jiahui Lim; Feaizen Koh; Sooim Ong; Sabrina Wong
Journal:  Diabetes Technol Ther       Date:  2012-10-04       Impact factor: 6.118

Review 4.  Hypoglycaemia in diabetes mellitus: epidemiology and clinical implications.

Authors:  Brian M Frier
Journal:  Nat Rev Endocrinol       Date:  2014-10-07       Impact factor: 43.330

5.  A prospective randomised cross-over study of the effect of insulin analogues and human insulin on the frequency of severe hypoglycaemia in patients with type 1 diabetes and recurrent hypoglycaemia (the HypoAna trial): study rationale and design.

Authors:  Peter Lommer Kristensen; Ulrik Pedersen-Bjergaard; Henning Beck-Nielsen; Kirsten Nørgaard; Hans Perrild; Jens Sandahl Christiansen; Tonny Jensen; Hans-Henrik Parving; Birger Thorsteinsson; Lise Tarnow
Journal:  BMC Endocr Disord       Date:  2012-06-22       Impact factor: 2.763

Review 6.  Drug-related risk of severe hypoglycaemia in observational studies: a systematic review and meta-analysis.

Authors:  Marcin Czech; Elżbieta Rdzanek; Justyna Pawęska; Olga Adamowicz-Sidor; Maciej Niewada; Michał Jakubczyk
Journal:  BMC Endocr Disord       Date:  2015-10-12       Impact factor: 2.763

7.  A method for the generation of human stem cell-derived alpha cells.

Authors:  Björn Tyrberg; Maria Sörhede-Winzell; Patrik Rorsman; Quinn P Peterson; Adrian Veres; Lihua Chen; Michael Q Slama; Jennifer H R Kenty; Shaimaa Hassoun; Matthew R Brown; Haiqiang Dou; Caden D Duffy; Quan Zhou; Aleksey V Matveyenko; Douglas A Melton
Journal:  Nat Commun       Date:  2020-05-07       Impact factor: 14.919

8.  A novel nasal powder formulation of glucagon: toxicology studies in animal models.

Authors:  Frederick E Reno; Patrick Normand; Kevin McInally; Sherwin Silo; Patricia Stotland; Myriam Triest; Dolores Carballo; Claude Piché
Journal:  BMC Pharmacol Toxicol       Date:  2015-10-26       Impact factor: 2.483

Review 9.  Hypoglycemia: The neglected complication.

Authors:  Sanjay Kalra; Jagat Jyoti Mukherjee; Subramanium Venkataraman; Ganapathi Bantwal; Shehla Shaikh; Banshi Saboo; Ashok Kumar Das; Ambady Ramachandran
Journal:  Indian J Endocrinol Metab       Date:  2013-09

10.  'I'm not a druggie, I'm just a diabetic': a qualitative study of stigma from the perspective of adults with type 1 diabetes.

Authors:  Jessica L Browne; Adriana Ventura; Kylie Mosely; Jane Speight
Journal:  BMJ Open       Date:  2014-07-23       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.